MCP
PRCT icon

Militia Capital Partners’s Procept Biorobotics PRCT Stock Holding History

Militia Capital Partners’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,200
Closed -$71.9K – 229
2025
Q3 		$71.9K Buy
+10,200
New +$466K 0.03% 169

Other funds holding PRCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Militia Capital Partners's PRCT Position: Q4 2025 in Review

Militia Capital Partners opened a new position in Procept Biorobotics (PRCT) in Q4 2025: 35,000 shares worth $1.1M. The stake represents 0.42% of the portfolio and ranks #78 among its holdings. This is a return to the name: Militia Capital Partners previously reported a position in PRCT as recently as Q2 2025.

Militia Capital Partners first reported a position in PRCT in Q1 2025 and has held it in 3 quarters since. The position peaked at $1.27M in Q2 2025. 263 funds tracked by Wall St. Rank hold PRCT as of Q4 2025.

  • Militia Capital Partners held 35,000 shares of Procept Biorobotics worth $1.1M as of Q4 2025.
  • Procept Biorobotics was a new Militia Capital Partners position in Q4 2025.
  • Procept Biorobotics made up 0.42% of Militia Capital Partners's portfolio in Q4 2025, its #78 holding.
  • Militia Capital Partners first reported a position in Procept Biorobotics in Q1 2025 and has held it in 3 quarters since.
  • Militia Capital Partners's Procept Biorobotics position peaked at $1.27M in Q2 2025.
  • 263 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2025.

Based on Militia Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.